- Home
- CCEL vs FBIO Comparison
CCEL vs FBIO Comparison
Compare CCEL & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEL | FBIO |
|---|---|---|
| Founded | 1989 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 113.9M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCEL | FBIO |
|---|---|---|
| Price | $3.45 | $3.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 4.3K | ★ 531.9K |
| Earning Date | 10-15-2025 | 11-14-2025 |
| Dividend Yield | ★ 11.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $31,747,500.00 | ★ $62,303,000.00 |
| Revenue This Year | $0.30 | $29.71 |
| Revenue Next Year | N/A | $49.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.45 | $1.33 |
| 52 Week High | $8.79 | $4.20 |
Technical Indicators
Market Signals| Indicator | CCEL | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 66.94 |
| Support Level | $3.58 | $3.31 |
| Resistance Level | $3.99 | $3.81 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 5.10 | 79.90 |
Price Performance
Historical ComparisonAbout CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.